HopeStage
Study directory

Personality disorders studies

Personality disorders involve lasting patterns of thinking, feeling or behaving that can cause distress and difficulties in relationships.

Back to overview
More filters: keywords, city, remote
550studies shown
Showing 289-300 of 550
Drug study icon
CompletedNCT04186403

Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)

Official study title

A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Adult Subjects With Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In New York
Personality disordersMedication studyAges 18–65
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Other study type icon
CompletedNCT01635556

Evaluation of a Modified Dialectical Behavior Therapy Program

Official study title

Evaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In Winnipeg
Personality disordersObservational studyAges 18–65
Countries
Canada
Sponsor
University of Manitoba
Behavioral study icon
UnknownNCT05710926

Evolutionary Systems Therapy for Schizotypy

Official study title

A Confirmatory Randomized Controlled Trial Comparing Evolutionary Systems Therapy for Schizotypal Personality Disorder With Cognitive Behavioral Therapy

Current recruitment status is unconfirmed.

In Florence
Personality disordersBehavioural studyAges 18+
Countries
Italy
Sponsor
Tages Onlus
Drug study icon
UnknownNCT00358969

Guanfacine to Treat Borderline Personality Disorder

Official study title

Guanfacine in the Treatment of Borderline Personality Disorder

Current recruitment status is unconfirmed.

In New York
Personality disordersMedication studyAges 18–55
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Behavioral study icon
CompletedNCT00154154

Hope for the Chronically Suicidal Patient

Official study title

Hope for the Chronically Suicidal Patient: Evaluating the Clinical and Health Services Impact of Dialectical Behaviour Therapy in Individuals With Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In Toronto
Personality disordersBehavioural studyAges 18–60
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Behavioral study icon
CompletedNCT06076343

Integrated Intervention for Borderline Personality Disorder and Caregivers

Official study title

An Integrated Approach to Treatment of People With Borderline Personality Disorder and Their Caregivers

This study has finished and is no longer accepting participants.

In Brescia
Personality disordersBehavioural studyAges 18–50
Countries
Italy
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Drug study icon
CompletedNCT05383300

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

Official study title

Investigating the Effect of Oxytocin and the Neurochemistry of Antisocial Personality Disorder and Psychopathy Using Neuroimaging

This study has finished and is no longer accepting participants.

In London
Personality disordersMedication studyAges 18–60
Countries
United Kingdom
Sponsor
King's College London (University)
Drug study icon
TerminatedNCT03395314

Ketamine in Borderline Personality Disorder

Official study title

A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder

This study ended early.

In New Haven
Personality disordersMedication studyAges 21–60
Countries
United States
Sponsor
Yale University
Behavioral study icon
CompletedNCT03361826

Magnetic Seizure Therapy for Borderline Personality Disorder

Official study title

Magnetic Seizure Therapy for the Treatment of Treatment-Resistant Depression and Suicidal Ideation in Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In Toronto
Personality disordersDevice studyAges 18–50
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.